US Stock MarketDetailed Quotes

SPRO Spero Therapeutics

Watchlist
  • 1.290
  • +0.110+9.32%
Close Nov 4 16:00 ET
  • 1.290
  • 0.0000.00%
Post 20:01 ET
69.72MMarket Cap3.79P/E (TTM)

Spero Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
663.58%6.02M
468.11%4.2M
99.13%96.74M
54.95%71.83M
2,061.00%23.38M
-12.05%788K
199.60%740K
1,482.38%48.58M
18,007.03%46.35M
52.82%1.08M
Operating revenue
663.58%6.02M
468.11%4.2M
99.13%96.74M
54.95%71.83M
2,061.00%23.38M
-12.05%788K
199.60%740K
1,482.38%48.58M
18,007.03%46.35M
52.82%1.08M
Cost of revenue
Gross profit
Operating expense
83.35%25.08M
21.51%18.19M
-11.62%69.95M
3.88%21.29M
53.12%20.01M
-9.58%13.68M
-50.85%14.97M
-13.07%79.15M
-26.16%20.5M
-43.75%13.07M
Selling and administrative expenses
-9.24%5.53M
-19.13%5.92M
-29.96%25.55M
-0.95%6.43M
-13.93%5.71M
-24.28%6.1M
-52.19%7.32M
-12.51%36.48M
-50.12%6.5M
-40.53%6.63M
-General and administrative expense
-9.24%5.53M
-19.13%5.92M
-29.96%25.55M
-0.95%6.43M
-13.93%5.71M
-24.28%6.1M
-52.19%7.32M
-12.51%36.48M
-50.12%6.5M
-40.53%6.63M
Research and development costs
149.47%23.73M
93.03%17.33M
8.08%51.44M
9.73%16.56M
122.73%16.39M
16.36%9.51M
-47.09%8.98M
-26.24%47.59M
-12.40%15.09M
-49.02%7.36M
Other operating expenses
-116.80%-4.18M
-280.96%-5.06M
-42.92%-7.05M
-56.12%-1.7M
-126.30%-2.09M
-75.75%-1.93M
27.06%-1.33M
67.54%-4.93M
56.31%-1.09M
60.78%-924K
Operating profit
-47.87%-19.06M
1.72%-13.98M
187.63%26.79M
95.43%50.53M
128.13%3.37M
9.42%-12.89M
52.90%-14.23M
65.25%-30.57M
194.02%25.86M
46.79%-11.99M
Net non-operating interest income expense
22.00%1.2M
37.80%1.33M
362.64%3.94M
45.87%1.04M
356.73%950K
16,466.67%982K
139.86%963K
5.96%-1.5M
138.36%715K
131.11%208K
Non-operating interest income
22.00%1.2M
37.80%1.33M
255.97%3.94M
45.87%1.04M
356.73%950K
784.68%982K
1,237.50%963K
219.65%1.11M
840.79%715K
131.11%208K
Non-operating interest expense
----
----
--0
--0
--0
----
----
34.28%2.61M
--0
--0
Other net income (expense)
116.67%1K
-600.00%-14K
62.92%-5.32M
-98.49%3K
-5,261.17%-5.32M
99.96%-6K
99.03%-2K
-7,412.57%-14.35M
57.94%199K
218.39%103K
Gain on sale of security
----
----
----
----
----
----
----
349.51%917K
--141K
---26K
Special income (charges)
----
----
54.38%-5.31M
--0
-3,590.79%-5.31M
----
----
---11.63M
--3.65M
--152K
-Less：Restructuring and merger&acquisition
----
----
--0
--0
--0
----
----
--11.63M
---67K
---152K
-Less:Impairment of capital assets
----
----
--5.31M
--0
--5.31M
----
----
--0
--0
--0
Other non- operating income (expenses)
116.67%1K
-600.00%-14K
99.61%-14K
100.08%3K
56.52%-10K
40.00%-6K
84.62%-2K
-820.51%-3.64M
-4,502.56%-3.59M
73.56%-23K
Income before tax
-49.92%-17.86M
4.50%-12.67M
154.73%25.4M
92.66%51.58M
91.49%-994K
58.46%-11.91M
59.59%-13.27M
48.29%-46.42M
191.56%26.77M
48.16%-11.68M
Income tax
2.6M
387K
2.21M
0
0
0
Net income
-49.92%-17.86M
4.50%-12.67M
149.13%22.81M
91.22%51.19M
72.55%-3.21M
58.46%-11.91M
59.59%-13.27M
48.29%-46.42M
191.56%26.77M
48.16%-11.68M
Net income continuous Operations
-49.92%-17.86M
4.50%-12.67M
149.13%22.81M
91.22%51.19M
72.55%-3.21M
58.46%-11.91M
59.59%-13.27M
48.29%-46.42M
191.56%26.77M
48.16%-11.68M
Minority interest income
Net income attributable to the parent company
-49.92%-17.86M
4.50%-12.67M
149.13%22.81M
91.22%51.19M
72.55%-3.21M
58.46%-11.91M
59.59%-13.27M
48.29%-46.42M
191.56%26.77M
48.16%-11.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-49.92%-17.86M
4.50%-12.67M
149.13%22.81M
91.22%51.19M
72.55%-3.21M
58.46%-11.91M
59.59%-13.27M
48.29%-46.42M
191.56%26.77M
48.16%-11.68M
Basic earnings per share
-43.48%-0.33
4.00%-0.24
134.96%0.43
76.36%0.97
81.82%-0.06
73.56%-0.23
75.25%-0.25
57.73%-1.23
159.78%0.55
52.86%-0.33
Diluted earnings per share
-43.48%-0.33
4.00%-0.24
134.96%0.43
76.36%0.97
81.82%-0.06
73.56%-0.23
75.25%-0.25
57.73%-1.23
159.78%0.55
52.86%-0.33
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 663.58%6.02M468.11%4.2M99.13%96.74M54.95%71.83M2,061.00%23.38M-12.05%788K199.60%740K1,482.38%48.58M18,007.03%46.35M52.82%1.08M
Operating revenue 663.58%6.02M468.11%4.2M99.13%96.74M54.95%71.83M2,061.00%23.38M-12.05%788K199.60%740K1,482.38%48.58M18,007.03%46.35M52.82%1.08M
Cost of revenue
Gross profit
Operating expense 83.35%25.08M21.51%18.19M-11.62%69.95M3.88%21.29M53.12%20.01M-9.58%13.68M-50.85%14.97M-13.07%79.15M-26.16%20.5M-43.75%13.07M
Selling and administrative expenses -9.24%5.53M-19.13%5.92M-29.96%25.55M-0.95%6.43M-13.93%5.71M-24.28%6.1M-52.19%7.32M-12.51%36.48M-50.12%6.5M-40.53%6.63M
-General and administrative expense -9.24%5.53M-19.13%5.92M-29.96%25.55M-0.95%6.43M-13.93%5.71M-24.28%6.1M-52.19%7.32M-12.51%36.48M-50.12%6.5M-40.53%6.63M
Research and development costs 149.47%23.73M93.03%17.33M8.08%51.44M9.73%16.56M122.73%16.39M16.36%9.51M-47.09%8.98M-26.24%47.59M-12.40%15.09M-49.02%7.36M
Other operating expenses -116.80%-4.18M-280.96%-5.06M-42.92%-7.05M-56.12%-1.7M-126.30%-2.09M-75.75%-1.93M27.06%-1.33M67.54%-4.93M56.31%-1.09M60.78%-924K
Operating profit -47.87%-19.06M1.72%-13.98M187.63%26.79M95.43%50.53M128.13%3.37M9.42%-12.89M52.90%-14.23M65.25%-30.57M194.02%25.86M46.79%-11.99M
Net non-operating interest income expense 22.00%1.2M37.80%1.33M362.64%3.94M45.87%1.04M356.73%950K16,466.67%982K139.86%963K5.96%-1.5M138.36%715K131.11%208K
Non-operating interest income 22.00%1.2M37.80%1.33M255.97%3.94M45.87%1.04M356.73%950K784.68%982K1,237.50%963K219.65%1.11M840.79%715K131.11%208K
Non-operating interest expense ----------0--0--0--------34.28%2.61M--0--0
Other net income (expense) 116.67%1K-600.00%-14K62.92%-5.32M-98.49%3K-5,261.17%-5.32M99.96%-6K99.03%-2K-7,412.57%-14.35M57.94%199K218.39%103K
Gain on sale of security ----------------------------349.51%917K--141K---26K
Special income (charges) --------54.38%-5.31M--0-3,590.79%-5.31M-----------11.63M--3.65M--152K
-Less：Restructuring and merger&acquisition ----------0--0--0----------11.63M---67K---152K
-Less:Impairment of capital assets ----------5.31M--0--5.31M----------0--0--0
Other non- operating income (expenses) 116.67%1K-600.00%-14K99.61%-14K100.08%3K56.52%-10K40.00%-6K84.62%-2K-820.51%-3.64M-4,502.56%-3.59M73.56%-23K
Income before tax -49.92%-17.86M4.50%-12.67M154.73%25.4M92.66%51.58M91.49%-994K58.46%-11.91M59.59%-13.27M48.29%-46.42M191.56%26.77M48.16%-11.68M
Income tax 2.6M387K2.21M000
Net income -49.92%-17.86M4.50%-12.67M149.13%22.81M91.22%51.19M72.55%-3.21M58.46%-11.91M59.59%-13.27M48.29%-46.42M191.56%26.77M48.16%-11.68M
Net income continuous Operations -49.92%-17.86M4.50%-12.67M149.13%22.81M91.22%51.19M72.55%-3.21M58.46%-11.91M59.59%-13.27M48.29%-46.42M191.56%26.77M48.16%-11.68M
Minority interest income
Net income attributable to the parent company -49.92%-17.86M4.50%-12.67M149.13%22.81M91.22%51.19M72.55%-3.21M58.46%-11.91M59.59%-13.27M48.29%-46.42M191.56%26.77M48.16%-11.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -49.92%-17.86M4.50%-12.67M149.13%22.81M91.22%51.19M72.55%-3.21M58.46%-11.91M59.59%-13.27M48.29%-46.42M191.56%26.77M48.16%-11.68M
Basic earnings per share -43.48%-0.334.00%-0.24134.96%0.4376.36%0.9781.82%-0.0673.56%-0.2375.25%-0.2557.73%-1.23159.78%0.5552.86%-0.33
Diluted earnings per share -43.48%-0.334.00%-0.24134.96%0.4376.36%0.9781.82%-0.0673.56%-0.2375.25%-0.2557.73%-1.23159.78%0.5552.86%-0.33
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data